BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 9510127)

  • 1. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
    Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
    Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native gel electrophoresis and isoelectric focusing of a 64-kilodalton eye muscle protein shows that it is an important target for serum autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle.
    Wall JR; Hayes M; Scalise D; Stolarski C; Nebes V; Kiljanski J; Salvi M; Sato M
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1226-32. PubMed ID: 7714092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
    Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J
    J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy.
    Kaspar M; Archibald C; De BA; Li AW; Yamada M; Chang CH; Kahaly G; Wall JR
    Thyroid; 2002 Mar; 12(3):187-91. PubMed ID: 11952037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of eye muscle antibody measurement in diagnosis of thyroid-associated ophthalmopathy: a laboratory update.
    Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall JR
    Endocr Pract; 1998; 4(3):127-32. PubMed ID: 15251739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
    Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
    J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
    Wu YJ; Clarke EM; Shepherd P
    Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens.
    Gunji K; Kubota S; Swanson J; Kiljanski J; Bednarczuk T; Wengrowicz S; Salvi M; Wall JR
    Thyroid; 1998 Jun; 8(6):553-6. PubMed ID: 9669297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirm their significance in thyroid-associated ophthalmopathy.
    Barsouk A; Wengrowicz S; Scalise D; Stolarski C; Nebes V; Sato M; Wall JR
    Thyroid; 1995 Jun; 5(3):195-200. PubMed ID: 7580267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.
    Wall JR; Triller H; Boucher A; Bernard NF; Salvi M; Ludgate M
    J Endocrinol Invest; 1993 Dec; 16(11):863-8. PubMed ID: 7511621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies in the serum of patients with autoimmune thyroid disorders react with a recombinant 98 amino acid fragment of a full length 64 kDa eye muscle membrane protein which is also expressed in the thyroid.
    Zhang ZG; Dong Q; Rodien P; Alcalde L; Bernard N; Boucher A; Salvi M; Arthurs B; Vassart GM; Ludgate M
    Autoimmunity; 1992; 13(2):151-7. PubMed ID: 1467436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
    Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
    Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against 1D, a recombinant 64-kDa membrane protein, are associated with ophthalmopathy in patients with thyroid autoimmunity.
    Bernard NF; Nygen TN; Tyutyunikov A; Stolarski C; Scalise D; Genovese C; Hayes MB; Ludgate M; Wall JR
    Clin Immunol Immunopathol; 1994 Mar; 70(3):225-33. PubMed ID: 8313659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.
    Tandon N; Yan SL; Arnold K; Metcalfe RA; Weetman AP
    Clin Endocrinol (Oxf); 1994 May; 40(5):629-39. PubMed ID: 8013144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative western blot.
    Hiromatsu Y; Sato M; Tanaka K; Shoji S; Nonaka K; Chinami M; Fukazawa H
    Autoimmunity; 1992; 14(1):9-16. PubMed ID: 1299352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.